Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: acyclovir|DRUG: acyclovir sodium|DRUG: valacyclovir
Sponsor: Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)